Two University of Arizona students have won their campus round of the Hult Prize with a hearing-aid venture built to reach patients who cannot travel to a clinic, the University of Arizona reported. Kian Sadat, an electrical and computer engineering student, and Safiya Tarazi, who studies neuroscience and cognitive science, are developing Ampira, a wearable device that a specialist can calibrate remotely using hearing-test data the device itself collects. The pitch is aimed at rural populations who would otherwise travel hundreds of miles to see an audiologist.
What Ampira is trying to do
Its central idea is remote calibration, the University of Arizona said. A patient in an underserved area wears the device, it records the hearing test, and an audiologist adjusts the settings from a distance, without the patient making the journey. Sadat said the team was “not interested in reusing old hearing aids from the ’80s and ’90s”, and wants a basic device built around automatic calibration and remote fitting. The founders are also developing a teleaudiology platform to sit alongside the hardware, so that follow-up care runs the same way as the fitting.
Access is the case the founders lead with. Tarazi said the venture was “about providing access to education and participation in the workforce”, not just about hearing, framing the device as a route into schooling, jobs and community for the people it reaches. That framing is what a competition judged on the United Nations Sustainable Development Goals tends to reward.
The Hult Prize and where it goes next
The Hult Prize is a student competition backed by the education firm EF Education First, the University of Arizona said, and it asks teams to build businesses around the 17 UN Sustainable Development Goals. Sadat and Tarazi won the campus qualifier, hosted by the W.A. Franke Honors College, in early February. The University of Arizona will host the western regional finals on 17 and 18 April, and the global final in September carries a 1 million dollar seed investment for the winner.
Scott Hessell, the Franke Honors College’s strategic partnership and innovation officer, ran the campus contest through a programme called The Venture Studio. Hessell said the competition lets students use the 17 sustainability goals as starting points for their own ideas, which is how a hearing-aid company came out of an honours college. Sadat is building prototypes in his dorm room with a 3D printer and plastic ear models, the University of Arizona said, and expects connectivity and calibration to be the hardest problems to solve.
Why this belongs in a medical tourism story
Ampira is the inverse of medical tourism. Medical tourism moves a patient across a border to reach care; Ampira tries to move the care to the patient and delete the journey. Both answer the same underlying problem, which is that expert treatment is concentrated in a few places and most patients are somewhere else. Remote calibration, telemedicine and portable devices are the tools that chip at that concentration from the demand side, the same logic behind countries building local capacity so their patients stop travelling. Nigeria has framed its own hospitals in exactly those terms, with one Lagos institute that says it cut outbound medical tourism, and startups are chasing the same market from the technology side, as with an AI platform that raised 600,000 dollars for medical tourism.
The honest caveat is that Ampira is early. There is no shipping product, no clinical results and no deployment yet, only a prototype, a competition win and a plan to sell in bulk to the NGOs that already work in poor and remote communities. A device that removes patient travel has to exist and work at scale before it removes anything.
What to watch
Two near dates are concrete. The western regional finals fall on 17 and 18 April, and the global final and its 1 million dollar prize come in September, so a place in the next round is the first checkable milestone. Past that, the questions are engineering ones the founders have already named: whether remote calibration holds up over the poor connectivity of the regions it wants to serve, and whether a working device reaches patients rather than staying a pitch. Until a calibrated device is fitted remotely to a real patient, Ampira is a promising entry, not a delivered alternative to the journey.